RxDoctor Payments DataLook up a doctor →

Holly Starnes

Family · Raleigh, NCNPI 1104099761

Payments from drug & device makers

$68,917in general payments, 2019–2025

Across 586 payments — averaging $117.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$61K
  • AbbVie$2K
  • MDD US Operations, LLC$526
  • UCB, Inc.$389
  • Amgen$370
  • Novartis$340
  • plus $4K from 45 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)206$61,291
AbbVie95$1,977
MDD US Operations, LLC40$526
UCB, Inc.18$389
Amgen21$370
Novartis20$340
E.r. Squibb & Sons, L.L.C.3$330
Eisai Inc.14$294
Argenx US, Inc.2$230
Lilly USA, LLC9$219
Impel Pharmaceuticals Inc.13$212
Axsome Therapeutics, Inc.5$198
Sanofi7$167
Teva Pharmaceuticals USA, Inc.12$162
Pfizer9$151
Biohaven Pharmaceutical Holding Company Ltd.8$131
Takeda Pharmaceuticals U.S.A., Inc.5$114
Biohaven Pharmaceuticals, Inc.6$105
Lundbeck LLC5$100
Bristol Myers Squibb5$99
Neurelis, Inc.6$98
Sunovion Pharmaceuticals Inc.7$96
Sumitomo Pharma America, Inc.2$95
Biogen6$94
CSL Behring5$94
Aucta Pharmaceuticals, Inc.7$92
Neurocrine Biosciences, Inc.5$82
SK Life Science, Inc.3$76
Upsher-smith Laboratories LLC4$70
Banner Life Sciences, LLC3$66
Boston Scientific1$55
Amneal Pharmaceuticals LLC3$54
Otsuka America Pharmaceutical, Inc.3$53
Johnson & Johnson(2 entities)3$53
Supernus Pharmaceuticals, Inc.3$50
Microtransponder, Inc.2$43
Merz Pharmaceuticals, LLC2$39
GRT US Holding, Inc.2$34
Collegium Pharmaceutical, Inc.2$33
EMD Serono, Inc.2$29
TG Therapeutics, Inc.1$25
Acadia Pharmaceuticals Inc2$24
Impel Pharmaceuticals LLC1$23
Janssen Scientific Affairs, LLC1$20
Aquestive Therapeutics, Inc.1$18
Avion Pharmaceuticals1$18
Acorda Therapeutics, Inc1$17
Grifols USA, LLC1$16
Kyowa Kirin, Inc.1$16
Arbor Pharmaceuticals, Inc.1$16
Currax Pharmaceuticals LLC1$13

How this compares

$68,917 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina →

Medicare billing

Part B allowed, 2024
$48,400
Medicare patients
376
Services billed
999

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Raleigh

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →